SAN MATEO, Calif.--(BUSINESS WIRE)--Arkose Labs, the leader in digital risk intelligence, enabling genuine users, mitigating bots and advancing fraud detection modules, today announced the launch of ...

In a highly anticipated move, the US Food and Drug Administration (FDA) has announced the final release of the Unique Device Identification (UDI) rule, reflecting a number of changes called for by ...

A coalition in late March sent a letter to FDA commissioner Andrew von Eschenbach supporting a mandatory unique device identification (UDI) system and asking him to set a timeline to implement one.

SAN MATEO, Calif.--(BUSINESS WIRE)--Arkose Labs, the leading proactive fraud deterrence provider, today announced the latest release of Arkose Device ID, a solution within the new Arkose Titan™ ...

The Food and Drug Administration last week released an amendment to its proposed rule for a unique device identification system released in July. The amendment shortens the originally proposed ...

A few short months from now, manufacturers of Class III medical devices must comply with FDA’s unique device identification (UDI) rule. Part 1 of this series focused on the need for companies to start ...

Starting in September, class II medical devices will be required to be equipped with a unique device identifier to be in compliance with UDI regulations. The U.S. Food and Drug Administration passed ...

The Association for Professionals in Infection Control and Epidemiology, joining with other members of the Advancing Patient Safety Coalition, has sent a letter to the FDA urging for the immediate ...